/PRNewswire/ The "Animal Therapeutics and Diagnostics Global Market Report 2024" has been added to ResearchAndMarkets.com s offering. The global animal.
Third Quarter 2023 Financial Results
Revenue of $1,068 million, representing 4% reported growth or 5% excluding the impact of foreign exchange rates
Reported Net Loss of $1,096 million,.
Second Quarter 2023 Financial Results
Revenue of $1,057 million, impacted by an estimated $90-$110 million of revenue related to customer purchasing shifted from the second quarter into the first.